Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $13,994 | 2 | 94.3% |
| Food and Beverage | $827.23 | 38 | 5.6% |
| Unspecified | $14.11 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharma AG | $13,994 | 2 | $0 (2023) |
| Novo Nordisk Inc | $378.11 | 18 | $0 (2024) |
| Biogen, Inc. | $116.11 | 3 | $0 (2024) |
| Abbott Laboratories | $115.00 | 5 | $0 (2024) |
| Lilly USA, LLC | $83.68 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $26.73 | 2 | $0 (2023) |
| Cardiovascular Systems Inc. | $25.40 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.07 | 1 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $18.43 | 1 | $0 (2020) |
| Boston Scientific Corporation | $15.77 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.81 | 12 | Novo Nordisk Inc ($85.09) |
| 2023 | $14,132 | 9 | Novartis Pharma AG ($13,994) |
| 2022 | $243.91 | 8 | Novo Nordisk Inc ($153.60) |
| 2021 | $58.97 | 4 | Novo Nordisk Inc ($46.44) |
| 2020 | $89.65 | 5 | Novo Nordisk Inc ($35.75) |
| 2019 | $28.28 | 2 | Boston Scientific Corporation ($15.77) |
| 2017 | $25.40 | 1 | Cardiovascular Systems Inc. ($25.40) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Neuromodulation | ||||||
| 09/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Diabetes Care | ||||||
| 06/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Neurology | ||||||
| 05/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 04/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
| 04/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Obesity | ||||||
| 01/19/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Diabetes Care | ||||||
| 01/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Diabetes | ||||||
| 12/16/2023 | Novartis Pharma AG | ZOLGENSMA (Biological) | Travel and Lodging | In-kind items and services | $13,938.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2023 | Novartis Pharma AG | ZOLGENSMA (Biological) | Travel and Lodging | In-kind items and services | $56.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Diabetes Care | ||||||
| 08/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Diabetes Care | ||||||
| 04/29/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Diabetes | ||||||
| 04/24/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: RESPIRATORY | ||||||
| 03/31/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $15.53 | General |
| 01/28/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: Diabetes | ||||||
| 10/20/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $93.35 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, SHAM-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRATHECAL OAV101 IN PATIENTS TYPE 2 SPINAL MUSCULAR ATROPHY (SMA) WHO ARE ? 2 TO < 18 YEARS OF AGE, TREATMENT NAIVE, SITTING, AND NEVER AMBULATORY | Novartis Pharmaceuticals Corporation | $14.11 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 313 | 840 | $75,411 | $51,949 |
| 2022 | 6 | 295 | 918 | $79,862 | $56,228 |
| 2021 | 7 | 308 | 937 | $78,633 | $56,846 |
| 2020 | 9 | 416 | 1,123 | $90,200 | $63,496 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 69 | 411 | $28,837 | $22,589 | 78.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 204 | $27,525 | $15,643 | 56.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 49 | 49 | $7,350 | $5,980 | 81.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 69 | $6,900 | $4,137 | 60.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $3,065 | $2,217 | 72.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 12 | 12 | $560.00 | $548.80 | 98.0% |
| 98966 | Telephone medical discussion provided by nonphysician professional, 5-10 minutes | Office | 2023 | 34 | 59 | $809.48 | $477.66 | 59.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $364.00 | $356.72 | 98.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 83 | 489 | $34,274 | $25,839 | 75.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 234 | $30,951 | $19,576 | 63.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $5,550 | $4,642 | 83.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 37 | 42 | $5,597 | $4,196 | 75.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 22 | $2,200 | $1,182 | 53.7% |
| 98966 | Telephone medical discussion provided by nonphysician professional, 5-10 minutes | Office | 2022 | 44 | 94 | $1,290 | $792.07 | 61.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 77 | 482 | $33,783 | $25,218 | 74.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 236 | $29,736 | $20,451 | 68.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 36 | 37 | $4,931 | $3,667 | 74.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $3,600 | $3,072 | 85.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 43 | $3,655 | $2,379 | 65.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 15 | $1,555 | $1,200 | 77.1% |
| 98966 | Telephone assessment and management service, 5-10 minutes of medical discussion | Office | 2021 | 48 | 100 | $1,372 | $859.41 | 62.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 104 | 614 | $43,035 | $33,832 | 78.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 85 | 206 | $25,956 | $15,024 | 57.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 53 | 53 | $7,063 | $5,423 | 76.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 80 | $6,800 | $3,596 | 52.9% |
About Dr. Leslie Nelson, MD
Dr. Leslie Nelson, MD is a Internal Medicine healthcare provider based in Desoto, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700826088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leslie Nelson, MD has received a total of $14,836 in payments from pharmaceutical and medical device companies, with $257.81 received in 2024. These payments were reported across 41 transactions from 13 companies. The most common payment nature is "Travel and Lodging" ($13,994).
As a Medicare-enrolled provider, Nelson has provided services to 1,332 Medicare beneficiaries, totaling 3,818 services with total Medicare billing of $228,519. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Desoto, TX
- Active Since 06/07/2006
- Last Updated 01/23/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700826088
Products in Payments
- ZOLGENSMA (Biological) $13,994
- Rybelsus (Drug) $155.73
- Ozempic (Drug) $140.66
- FREESTYLE LIBRE (Device) $100.80
- JARDIANCE (Drug) $51.21
- RYBELSUS (Drug) $36.61
- MOUNJARO (Drug) $32.47
- Peripheral Orbital Atherectomy System (Device) $25.40
- SPINRAZA (Biological) $24.38
- TRADJENTA (Drug) $24.07
- Wegovy (Drug) $23.11
- Livalo (Drug) $18.43
- WATCHMAN (Device) $15.77
- TRELEGY ELLIPTA (Drug) $14.22
- PROCLAIM (Device) $14.20
- Edarbyclor (Drug) $12.53
- ANORO (Drug) $12.51
- JANUVIA (Drug) $11.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Desoto
Shehetaj Abdurrahim, Md, MD
Internal Medicine — Payments: $5,129
Yashwanth Jasti, M.d, M.D
Internal Medicine — Payments: $3,598
Dr. Donald Nicholas, M.d, M.D
Internal Medicine — Payments: $3,524
Dr. Ikechukwu Osuji, Md, MD
Internal Medicine — Payments: $3,184
Venkata Yalamanchili, M.d, M.D
Internal Medicine — Payments: $2,985
Dr. Kusi Fordjour, Md, MD
Internal Medicine — Payments: $2,474